These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23043942)

  • 1. Modulation of TLR9 response in a mouse model of herpes simplex virus encephalitis.
    Boivin N; Menasria R; Piret J; Boivin G
    Antiviral Res; 2012 Dec; 96(3):414-21. PubMed ID: 23043942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis.
    Boivin N; Sergerie Y; Rivest S; Boivin G
    J Infect Dis; 2008 Sep; 198(5):664-72. PubMed ID: 18662130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced viral clearance and reduced leukocyte infiltration in experimental herpes encephalitis after intranasal infection of CXCR3-deficient mice.
    Zimmermann J; Hafezi W; Dockhorn A; Lorentzen EU; Krauthausen M; Getts DR; Müller M; Kühn JE; King NJC
    J Neurovirol; 2017 Jun; 23(3):394-403. PubMed ID: 28116674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir combined with artesunate or rapamycin improves the outcome of herpes simplex virus encephalitis in mice compared to antiviral therapy alone.
    Canivet C; Menasria R; Rhéaume C; Piret J; Boivin G
    Antiviral Res; 2015 Nov; 123():105-13. PubMed ID: 26374952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
    Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
    Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TLR3 and TLR9 agonists improve postexposure vaccination efficacy of live smallpox vaccines.
    Israely T; Melamed S; Achdout H; Erez N; Politi B; Waner T; Lustig S; Paran N
    PLoS One; 2014; 9(10):e110545. PubMed ID: 25350003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis.
    Boivin N; Menasria R; Piret J; Rivest S; Boivin G
    Antiviral Res; 2013 Dec; 100(3):649-53. PubMed ID: 24416771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.
    Herbst-Kralovetz MM; Pyles RB
    J Virol; 2006 Oct; 80(20):9988-97. PubMed ID: 17005677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection.
    Lima GK; Zolini GP; Mansur DS; Freire Lima BH; Wischhoff U; Astigarraga RG; Dias MF; das Graças Almeida Silva M; Béla SR; do Valle Antonelli LR; Arantes RM; Gazzinelli RT; Báfica A; Kroon EG; Campos MA
    Am J Pathol; 2010 Nov; 177(5):2433-45. PubMed ID: 20864677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles played by toll-like receptor-9 in corneal endothelial cells after herpes simplex virus type 1 infection.
    Takeda S; Miyazaki D; Sasaki S; Yamamoto Y; Terasaka Y; Yakura K; Yamagami S; Ebihara N; Inoue Y
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6729-36. PubMed ID: 21778270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
    Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
    Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The chemokine CCL5 is essential for leukocyte recruitment in a model of severe Herpes simplex encephalitis.
    Vilela MC; Mansur DS; Lacerda-Queiroz N; Rodrigues DH; Lima GK; Arantes RM; Kroon EG; da Silva Campos MA; Teixeira MM; Teixeira AL
    Ann N Y Acad Sci; 2009 Feb; 1153():256-63. PubMed ID: 19236348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Early Microglial Response Is Needed To Efficiently Control Herpes Simplex Virus Encephalitis.
    Uyar O; Laflamme N; Piret J; Venable MC; Carbonneau J; Zarrouk K; Rivest S; Boivin G
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32938766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
    Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
    J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
    Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
    J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1.
    Ikemoto K; Pollard RB; Fukumoto T; Morimatsu M; Suzuki F
    J Immunol; 1995 Aug; 155(3):1326-33. PubMed ID: 7636198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way.
    Gaajetaan GR; Geelen TH; Grauls GE; Bruggeman CA; Stassen FR
    Antiviral Res; 2012 Jan; 93(1):39-47. PubMed ID: 22057305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifications incorporated in CpG motifs of oligodeoxynucleotides lead to antagonist activity of toll-like receptors 7 and 9.
    Yu D; Wang D; Zhu FG; Bhagat L; Dai M; Kandimalla ER; Agrawal S
    J Med Chem; 2009 Aug; 52(16):5108-14. PubMed ID: 19650625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain.
    Sørensen LN; Reinert LS; Malmgaard L; Bartholdy C; Thomsen AR; Paludan SR
    J Immunol; 2008 Dec; 181(12):8604-12. PubMed ID: 19050280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA.
    Ashkar AA; Yao XD; Gill N; Sajic D; Patrick AJ; Rosenthal KL
    J Infect Dis; 2004 Nov; 190(10):1841-9. PubMed ID: 15499542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.